| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $4.7B | $5.2B | $3.3B | $0.8B | $0.4B | $0.3B | $0.3B |
| Cost of Revenue | $3.8B | $3.3B | $3.5B | $2.1B | $0.5B | $0.2B | $0.2B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.6B | $0.5B | $0.5B | $0.4B | $0.1B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.9B | $0.9B | $1.0B | $0.5B | $0.1B | $0.1B | $0.1B | $0.0B |
| Operating Income | — | $0.1B | $-0.0B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.0B | $-0.2B | $-0.3B | $0.2B | $0.3B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $-0.52 | $-1.84 | $-2.93 | $1.57 | $0.62 | $0.44 | $0.44 | $0.52 |
| EPS (Diluted) | $-0.52 | $-1.84 | $-2.93 | $1.45 | $0.59 | $0.43 | $0.42 | $0.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.9B | $14.5B | $13.7B | $7.8B | $6.5B | $2.0B | $1.8B | $1.5B |
| Current Assets | $3.9B | $3.7B | $3.3B | $4.3B | $3.0B | $0.8B | $0.8B | $0.7B |
| Cash & Equivalents | $0.9B | $0.9B | — | — | $1.6B | $0.2B | $0.2B | $0.3B |
| Total Liabilities | $6.4B | $6.5B | $6.5B | $3.5B | $2.4B | $0.8B | $0.7B | $0.6B |
| Current Liabilities | $1.8B | $1.3B | $1.1B | $1.3B | $0.7B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $5.6B | $5.2B | $5.0B | $3.6B | $3.4B | $1.1B | $1.0B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.6B | $0.4B | $0.6B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-5.9B | $-0.3B | $-0.2B | $-0.2B | $-0.3B | — |
| Capital Expenditures | $0.4B | $0.3B | $0.4B | $0.3B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.5B | $0.8B | $3.6B | $0.9B | $0.7B | $0.0B | $0.1B | $0.1B |